July 24, 2014 5:39 PM ET

Pharmaceuticals

Company Overview of Artielle ImmunoTherapeutics, Inc.

Company Overview

Artielle ImmunoTherapeutics, Inc., a biopharmaceutical company, develops recombinant T-cell receptor ligands (RTLs) to treat T-cell mediated inflammatory diseases. It develops RTL1000, a compound for the treatment of multiple sclerosis. The company focuses on the development of therapeutics for the treatment of autoimmune diseases that include multiple sclerosis, celiac disease, type 1 diabetes, rheumatoid arthritis, uveitis, stroke, optic neuritis, and other diseases. Artielle ImmunoTherapeutics, Inc. was founded in 2004 and is based in Tigard, Oregon.

9020 SW Washington Square Road

Suite 450

Tigard, OR 97223

United States

Founded in 2004

Phone:

503-626-1144

Fax:

503-627-0984

Key Executives for Artielle ImmunoTherapeutics, Inc.

Chairman of The Board and Chief Executive Officer
President and Director
Age: 71
Founding Scientist
Founding Scientist
Founding Scientist
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
FSI Nutritional Products, LLC United States
Summit Biosciences Inc. United States
Advanced Biosearch Associates United States
Lupin Pharmaceuticals, Inc. United States
Great Southern Laboratories, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Artielle ImmunoTherapeutics, Inc., please visit www.artielle.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.